Request demo
Picture of Helen Johnstone

Helen Johnstone

Science Resources

No current resources

News Articles

Torx software release enhances CRO management capabilities
Cambridge, UK – May 15, 2023 – Torx® Software Limited, provider of Torx for management of small molecule discovery chemistry, announces...
Unique molecule life cycle platform released: Torx® 2.0
Cambridge, UK – June 13th 2023 – Torx ® Software Limited, announces the release of Torx 2.0, extending the platform’s scientific reach and capabilities...
Torx® Software announces global drug discovery collaboration with CDD Vault®
September 12th, 2023, Cambridge, UK –  – Torx® Software Limited announces a collaboration with CDD Vault to...
Cresset Aims to Optimize Drug Discovery with Latest Drug Design Platform Release
January 29th 2024, Cambridge, UK – Cresset, a provider of integrated in silico solutions for drug discovery, has released the latest version...
Cresset® Announces Global Collaboration with Enamine on New Virtual Screening Drug Discovery Technology
February 21st 2024 – Cambridge, UK – Cresset, an innovative provider of integrated in silico solutions for drug discovery announces a collaboration...
Cresset Increases North American Presence with New Boston Site
Cambridge, UK, 6th March 2024 – Cresset, a provider of integrated in silico solutions for drug discovery has expanded its existing North...
Cresset® Creates New Vice President Role to Lead their Artificial Intelligence (AI) Strategy
Cambridge, 15th April 2024 – Cresset an innovative provider of solutions for CADD, DMTA efficiency, and contract research, has expanded its senior...
Cresset® appoints new Chairman
Cambridge, 13th May 2024 – Cresset, innovative provider of computational drug discovery and development solutions that accelerate research...
Cresset® appoints new Non-Executive Director
Cambridge, 20th May 2024 – Cresset, innovative provider of computational drug discovery and development solutions that accelerate research...
Cresset successfully achieves SOC 2 compliance
Cresset is pleased to announce the successful completion of its SOC 2®  (System and Organization Controls 2) Type 1 audit, achieving...
Cresset sponsor new boat and outreach initiatives at City of Cambridge Rowing Club
  Cresset are proud to support local organizations and those close to the heart of our colleagues. We have recently sponsored a new boat at...
Cresset’s Drug Discovery Tool Unlocks the Creative Potential of Molecule Design
22nd July 2024 – Cambridge, UK – Cresset®, a leading provider of integrated in silico solutions for drug discovery announces the...
Cresset® collaborates with global leaders Enamine to enable the design of exciting new Targeted Protein Degraders
02 August 2024 – Cambridge, UK – Cresset, an innovative provider of integrated in silico solutions for drug discovery, announces an extension...
Cresset Newsletter January 2025
Welcome to the January Cresset Newsletter   Webinar: Active Learning FEP using 3D-QSAR for prioritizing bioisosteres in medicinal chemistry...
Cresset Newsletter March 2025
Welcome to the March Cresset Newsletter   Bio-IT World We’re looking forward to attending Bio-IT World next week, 2nd – 4th...
PI Health Sciences Announces Strategic Collaboration with Cresset
Mumbai, India – May 15, 2025 – PI Health Sciences (PIHS), a leading global provider of integrated drug discovery and development solutions and...
Cresset Newsletter May 2025
If you haven’t already done so, we invite you to register and join us for the latest in our Flare™ V10 release webinar series. In this session...
Cresset Newsletter June 2025
Welcome to the June Cresset newsletter.   Publication Features: ACS Medicinal Chemistry Letters We are delighted to have two of our new papers...
Cresset Acquires Molab.ai to Advance Digitization of Drug Discovery
July 8th 2025 – Cambridge UK – Cresset, a leading provider of innovative solutions for the digitization of drug discovery, announces the acquisition...
Cresset Newsletter July 2025
Welcome to the July Cresset newsletter. Cresset acquires Molab.ai We are delighted to announce that Cresset® have acquired Molab.ai, a pioneer...
Cresset Newsletter September 2025
Come and meet the Cresset team at BiotechX Europe and discover how our advanced computational chemistry technologies drive innovation across...
Cresset Newsletter October 2025
BioTechX Europe 2025 The presentation “Active Learning FEP Using 3D-QSAR for Prioritizing Bioisosteres in Medicinal Chemistry” by Dr. Mark...

Blog

Torx software release enhances CRO management capabilities
Cambridge, UK – May 15, 2023 – Torx® Software Limited, provider of Torx for management of small molecule discovery chemistry, announces...
Unique molecule life cycle platform released: Torx® 2.0
Cambridge, UK – June 13th 2023 – Torx ® Software Limited, announces the release of Torx 2.0, extending the platform’s scientific reach and capabilities...
Torx® Software announces global drug discovery collaboration with CDD Vault®
September 12th, 2023, Cambridge, UK –  – Torx® Software Limited announces a collaboration with CDD Vault to...
Cresset Aims to Optimize Drug Discovery with Latest Drug Design Platform Release
January 29th 2024, Cambridge, UK – Cresset, a provider of integrated in silico solutions for drug discovery, has released the latest version...
Cresset® Announces Global Collaboration with Enamine on New Virtual Screening Drug Discovery Technology
February 21st 2024 – Cambridge, UK – Cresset, an innovative provider of integrated in silico solutions for drug discovery announces a collaboration...
Cresset Increases North American Presence with New Boston Site
Cambridge, UK, 6th March 2024 – Cresset, a provider of integrated in silico solutions for drug discovery has expanded its existing North...
Cresset® Creates New Vice President Role to Lead their Artificial Intelligence (AI) Strategy
Cambridge, 15th April 2024 – Cresset an innovative provider of solutions for CADD, DMTA efficiency, and contract research, has expanded its senior...
Cresset® appoints new Chairman
Cambridge, 13th May 2024 – Cresset, innovative provider of computational drug discovery and development solutions that accelerate research...
Cresset® appoints new Non-Executive Director
Cambridge, 20th May 2024 – Cresset, innovative provider of computational drug discovery and development solutions that accelerate research...
Cresset successfully achieves SOC 2 compliance
Cresset is pleased to announce the successful completion of its SOC 2®  (System and Organization Controls 2) Type 1 audit, achieving...
Cresset sponsor new boat and outreach initiatives at City of Cambridge Rowing Club
  Cresset are proud to support local organizations and those close to the heart of our colleagues. We have recently sponsored a new boat at...
Cresset’s Drug Discovery Tool Unlocks the Creative Potential of Molecule Design
22nd July 2024 – Cambridge, UK – Cresset®, a leading provider of integrated in silico solutions for drug discovery announces the...
Cresset® collaborates with global leaders Enamine to enable the design of exciting new Targeted Protein Degraders
02 August 2024 – Cambridge, UK – Cresset, an innovative provider of integrated in silico solutions for drug discovery, announces an extension...
Cresset Newsletter January 2025
Welcome to the January Cresset Newsletter   Webinar: Active Learning FEP using 3D-QSAR for prioritizing bioisosteres in medicinal chemistry...
Cresset Newsletter March 2025
Welcome to the March Cresset Newsletter   Bio-IT World We’re looking forward to attending Bio-IT World next week, 2nd – 4th...
PI Health Sciences Announces Strategic Collaboration with Cresset
Mumbai, India – May 15, 2025 – PI Health Sciences (PIHS), a leading global provider of integrated drug discovery and development solutions and...
Cresset Newsletter May 2025
If you haven’t already done so, we invite you to register and join us for the latest in our Flare™ V10 release webinar series. In this session...
Cresset Newsletter June 2025
Welcome to the June Cresset newsletter.   Publication Features: ACS Medicinal Chemistry Letters We are delighted to have two of our new papers...
Cresset Acquires Molab.ai to Advance Digitization of Drug Discovery
July 8th 2025 – Cambridge UK – Cresset, a leading provider of innovative solutions for the digitization of drug discovery, announces the acquisition...
Cresset Newsletter July 2025
Welcome to the July Cresset newsletter. Cresset acquires Molab.ai We are delighted to announce that Cresset® have acquired Molab.ai, a pioneer...
Cresset Newsletter September 2025
Come and meet the Cresset team at BiotechX Europe and discover how our advanced computational chemistry technologies drive innovation across...
Cresset Newsletter October 2025
BioTechX Europe 2025 The presentation “Active Learning FEP Using 3D-QSAR for Prioritizing Bioisosteres in Medicinal Chemistry” by Dr. Mark...